NCT07162857

Brief Summary

This randomized controlled study investigates the value of critical care ultrasound and non-invasive cardiac output monitoring in guiding fluid resuscitation for patients with septic shock in the emergency department. A total of 60 patients are randomly assigned to receive either ultrasound-guided or NICOM-guided fluid management, with both groups receiving standard sepsis care according to the 2021 Surviving Sepsis Campaign guidelines. The study aims to evaluate whether these monitoring modalities can optimize hemodynamic management, improve prognosis, and support clinical decision-making in emergency settings. Primary and secondary outcomes include early resuscitation efficacy (time to achieve mean arterial pressure ≥65 mmHg and lactate clearance), total fluid volume within the first 6 hours, incidence of complications (pulmonary edema, renal injury, ARDS), length of stay in the emergency department and hospital, and 28-day mortality. By comparing these two approaches, this study seeks to provide evidence for selecting appropriate monitoring tools to achieve precise and individualized fluid resuscitation in septic shock.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

August 16, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

September 9, 2025

Completed
Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

2.1 years

First QC Date

August 16, 2025

Last Update Submit

September 16, 2025

Conditions

Keywords

critical care ultrasoundnoninvasive cardiac output monitoringeptic shockfluid resuscitation

Outcome Measures

Primary Outcomes (2)

  • 28-day mortality rate

    Proportion of patients who die within 28 days after enrollment. Mortality will be assessed using hospital records and survival follow-up.

    28 days from enrollment

  • 28-Day Survival

    Proportion of patients who survive at 28 days after enrollment.

    28 days from enrollment

Secondary Outcomes (10)

  • ICU hospitalization time

    From enrollment to the end of treatment at 4 weeks

  • Use of Mechanical Ventilation

    From enrollment to the end of treatment at 4 weeks

  • Duration of Mechanical Ventilation

    From enrollment to the end of treatment at 4 weeks

  • Use of Vasopressor Therapy

    From enrollment to the end of treatment at 4 weeks

  • Time to Achieve Mean Arterial Pressure ≥65 mmHg

    Within the first 6 hours after enrollment

  • +5 more secondary outcomes

Study Arms (2)

Critical Care Ultrasound Group

EXPERIMENTAL

patients underwent immediate bedside assessment using a Philips EPIQ 5 color Doppler ultrasound system equipped with both phased-array (1.5-4.0 MHz) and convex-array (2.0-5.0 MHz) transducers. The initial ultrasound evaluation was completed within 10 minutes of enrollment and included comprehensive hemodynamic monitoring: inferior vena cava diameter (IVC) and collapsibility index (IVC-CI) for volume status assessment, left ventricular ejection fraction (LVEF) and end-diastolic volume (LVEDV) for cardiac function evaluation, ventricular wall motion analysis, along with pulmonary B-line quantification to assess pulmonary edema.

Device: Ultrasonic technology

Non-Invasive Cardiac Output Monitoring (NICOM) Group

EXPERIMENTAL

In the noninvasive cardiac output monitoring group, continuous hemodynamic assessment was performed using the NICOM system based on thoracic bioreactance technology.

Device: non-invasive cardiac output monitoring

Interventions

Monitoring commenced immediately after enrollment, with baseline parameters recorded after signal stabilization (≤5 minutes), including cardiac output (CO), stroke volume (SV), stroke volume variation (SVV), and systemic vascular resistance (SVR). The system automatically updated these parameters every 30 seconds and displayed them in real-time on the monitor screen. Fluid resuscitation was dynamically adjusted according to these continuous measurements until achieving the predefined therapeutic targets.

Non-Invasive Cardiac Output Monitoring (NICOM) Group

In the critical care ultrasound group, patients underwent immediate bedside This protocol ensured real-time, comprehensive evaluation of both cardiac function and fluid status to guide resuscitation.Ultrasound reassessment was performed every 1-2 hours to dynamically adjust both the volume and rate of fluid administration until predefined resuscitation targets were achieved.

Critical Care Ultrasound Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of septic shock in accordance with the Surviving Sepsis Campaign International ;
  • receipt of initial fluid resuscitation in the emergency department with a hospital stay of at least 6 hours;
  • age ≥ 18 years;
  • provision of informed consent.
  • Excluded criteria:
  • contraindications to rapid fluid administration (e.g., end-stage renal disease, end-stage heart failure, acute pulmonary edema);
  • inability to comply with treatment, such as patients with severe trauma, burns, cancer undergoing chemotherapy, pregnant or lactating women, and those with mental illness;
  • withdrawal from treatment or transfer to another facility within 24 hours of admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Panyu Central Hospital Affiliated to Guangzhou Medical University

Guangzhou, Guangdong, 510000, China

Location

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • yingshen wen

    Guangzhou Panyu Central Hospital, Guangzhou, Guangdong , China

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Emergency Department Attending Physician,Guangzhou Panyu Central Hospital

Study Record Dates

First Submitted

August 16, 2025

First Posted

September 9, 2025

Study Start

July 5, 2023

Primary Completion

July 31, 2025

Study Completion

July 31, 2025

Last Updated

September 22, 2025

Record last verified: 2025-09

Locations